参考文献/References:
[1] BRONI. A, COEN-HERAK D, MARGETI. S, et al. Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer.[J]. Biochemia Medica, 2019, 29(2): 20503.
[2] THAM C, LEE K, LAFFAN M. Utility of fibrinogen in the coagulation screen.[J]. British Journal of Haematology, 2019, 186(5): e137-e139.
[3] WANG Zhan, FAN Hua, WANG Wenda, et al. High preoperative plasma fibrinogen independently predicts a poor prognosis in patients with nonmetastatic RCC[J]. Journal of Cancer, 2020, 11(9): 2401-2407.
[4] PEDRAZZANI C, MANTOVANI G, SALVAGNO G L, et al. Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer[J]. World Journal of Gastroenterology, 2016, 22(45): 9994-10001.
[5] TROPPAN KT, MELCHARDT T, WENZL K, et al. The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.[J]. Journal of Clinical Pathology, 2016, 69(4): 326-330.
[6] THURNER E M, KRENN-PILKO S, LANGSENLEHNER, U et al. The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients[J]. World Journal of Urology, 2015, 33(10): 1467-1473.
[7] Clinical and Laboratory Standards Institute. CLSI EPq-A2 Method comparison and bias estimation using patient samples; Approved guideline-Second edition:(Interim Revision) [S].Wayne: PA, CLSI EP9-A2,2002.
[8] Clinical and Laboratory Standards Institute. CLSI EP14-A3. Evaluation of commutability of processed samples; Approved guideline-Third edition:EP14-A3[S]. Wayne:PA,CLSI EP14-A3,2014.
[9] 中华人民共和国卫生部，WS/T356-2011基质效应与互通性评估指南[S].北京：中国标准出版社, 2011. Ministry of Health People’s Republic of China. WS/T 356-2011.Guideline for evaluation of matrix effects and commutability[S]. Beijing:China standard Press, 2011.
[10] SOLOMON C, BARYSHNIKOVA E, Tripodi A, et al. Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: analysis of repeatability and agreement of Clauss method within and between six different laboratories.[J]. Thrombosis and Haemostasis, 2014, 112(1): 109-117.
[11] 张芹，欧阳红梅，甸自金，等. 2种全自动血凝分析仪凝血四项检测结果的比对研究[J]. 国际检验医学杂志, 2013, 34(2): 205-206. ZHANG Qin, OUYANG Hongmei ,DIAN Zijin, et al. Comparative study on four coagulation test results of two kinds of Automatic Coagulation Analyzer [J]. Int J Lab Med, 2013, 34(02): 205-206.
[12] 刘艳红,李臣宾,周文宾,等.纤维蛋白原检测参考物质的互通性研究[J].中华医学杂志，2019，99(26):2062-2067. LIU Yanhong,LI Chenbin, ZHOU Wenbin, et al. Study on commutability evaluation of reference materials for fibrinogen.[J]. National Medical Journal of China, 2019, 99(26): 2062-2067.
[13] 颜存粮，彭黎明，黄海雄. 不同血凝分析仪检测结果的一致性研究[J]. 中华检验医学杂志, 2008(01): 100-103. YAN Cunliang, PENG liming, HUANG Haixiong. Harmonization of the result of automated coagulation tests with different analyzers [J]. Clin J Lab Med, 2008 (1): 100-103.
[14] 阳建,余赛红,文艳,等.2种全自动血凝分析仪检测结果的线性分析[J]. 国际检验医学杂志, 2013, 34(23): 3226-3227. YANG Jian, YU Saihong ,WEN Yan, et al. Two full automatic blood coagulation analyzer test results of linear analysis [J]. Int J Lab Med, 2013, 34 (23) : 3226-3227.
[15] AGGARWAL S, NAYAK D M, MANOHAR C. Discrepancy in optical & mechanical method in coagulation tests in a turbid sample[J]. Indian Journal of Hematology and Blood Transfusion, 2014, 30suppl(1): 402-404.
[16] 寿玮龄，崔巍. 血栓与止血检验过程中实验室与临床沟通的重要性[J]. 中华医学杂志, 2016, 96(24): 1888-1891. SHOU Weiling, CUI Wei. The importance of communication between laboratory and clinic for hemostasis and thrombosis tests [J]. National Medical Journal of China, 2016, 96 (24) : 1888-1891.
[17] GREG MILLER W, MYERS GL, REJ R. Why commutability matters[J]. Clinical Chemistry, 2006, 52(4): 553-554.
相似文献/References:
[1]何晓璇a,王 刚a,郭 炫a,等.FIB,DD和FDP在高血压肾损伤中的变化及临床意义[J].现代检验医学杂志,2016,31(02):73.[doi:10.3969/j.issn.1671-7414.2016.02.022]
HE Xiao-xuana,WANG Ganga,GUO Xuana,et al.Changes and Clinical Significance Observation on FIB,
DD and FDP in Renal Impairment of Hypertension[J].Journal of Modern Laboratory Medicine,2016,31(02):73.[doi:10.3969/j.issn.1671-7414.2016.02.022]
[2]洪骏,王锋,印中鹏,等.冠心病患者血浆纤维蛋白原与脂蛋白相关磷脂酶A2水平[J].现代检验医学杂志,2015,30(05):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
HONG Jun,WANG Feng,YIN Zhong-peng,et al.Levels of Plasma Lipoprotein Associated Phospholipase A2
and Fibrinogen in Patients with Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2015,30(02):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
[3]杨伏猛,刘倩,王文军.胆红素对ACL TOP700全自动血凝仪检测凝血四项结果的影响[J].现代检验医学杂志,2015,30(05):132.[doi:10.3969/j.issn.1671-7414.2015.05.041]
YANG Fu-meng,LIU Qian,WANG Wen-jun.Effects of Bilirubin on ACL TOP700 Automated Coagulation
Analyzer to Detect Four Indexes of Coagulation[J].Journal of Modern Laboratory Medicine,2015,30(02):132.[doi:10.3969/j.issn.1671-7414.2015.05.041]
[4]邰祺雯,胡晓芳.心脏瓣膜置换术患者血浆纤维蛋白原水平动态变化监测的临床价值[J].现代检验医学杂志,2019,34(01):133.[doi:10.3969/j.issn.1671-7414.2019.01.035]
TAI Qi-wen,HU Xiao-fang.Clinical Value of Monitoring the Dynamic Changes of Plasma
Fibrinogen in Patients Undergoing Heart Valve Replacement[J].Journal of Modern Laboratory Medicine,2019,34(02):133.[doi:10.3969/j.issn.1671-7414.2019.01.035]
[5]刘倩倩,鲁作华,王 星,等.血浆D- 二聚体在2 型糖尿病患者早期肾损伤中的应用价值[J].现代检验医学杂志,2020,35(04):134.[doi:10.3969/j.issn.1671-7414.2020.04.034]
LIU Qian-qian,LU Zuo-hua,WANG Xing,et al.Application Value of Serum D-Dimer in Early Kidney Injury in Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2020,35(02):134.[doi:10.3969/j.issn.1671-7414.2020.04.034]
[6]谭 雍,严 敏,程 珍,等.433例肺血栓栓塞症患者血液 C-反应蛋白、抗凝血酶和纤维蛋白原及血液学变化特点分析[J].现代检验医学杂志,2022,37(01):203.[doi:10.3969/j.issn.1671-7414.2022.01.042]
TAN Yong,YAN Min,CHENG Zhen,et al.Analysis of Change Feature of CRP ,Antithrombin, Fibrinogen and Hematological Indexs in 433 Patients with PulmonaryThromboembolism[J].Journal of Modern Laboratory Medicine,2022,37(02):203.[doi:10.3969/j.issn.1671-7414.2022.01.042]
[7]马 聪,徐志伟,高彦琳,等.射血分数保留型心力衰竭患者血浆纤维蛋白原水平与易损期预后的预测价值研究[J].现代检验医学杂志,2023,38(04):180.[doi:10.3969/j.issn.1671-7414.2023.04.033]
MA Cong,XU Zhiwei,GAO Yanlin,et al.Study on the Predictive Value of Plasma Fibrinogen Level and Vulnerable Stage Prognosis in Patients with Ejection Fraction Preserving Heart Failure[J].Journal of Modern Laboratory Medicine,2023,38(02):180.[doi:10.3969/j.issn.1671-7414.2023.04.033]
[8]蒋红英,王依阳,赵 慧,等.冠心病PCI 术后患者血液FIB，NLRP3 和LECT-2 水平表达与冠状动脉微血管疾病发生的相关性研究[J].现代检验医学杂志,2023,38(06):35.[doi:10.3969/j.issn.1671-7414.2023.06.007]
JIANG Hongying,WANG Yiyang,ZHAO Hui,et al.Correlation between Blood FIB, NLRP3 and LECT-2 Expression Levels and the Development of Coronary Microvascular Disease in Patients with Coronary Artery Disease after PCI[J].Journal of Modern Laboratory Medicine,2023,38(02):35.[doi:10.3969/j.issn.1671-7414.2023.06.007]